Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Rucaparib (AG014699) tartrate is an orally active inhibitor of PARP proteins (PARP-1, PARP-2 and PARP-3) and acts on PARP-1 (Ki: 1.4 nM).Rucaparib tartrate is a hexose hexaphosphate dehydrogenase (H6PD) inhibitor. Rucaparib tartrate has potential for use in the study of destructive resistant prostate cancer (CRPC).
パッケージサイズ | 在庫状況 | 単価(税別) |
---|---|---|
25 mg | 約6-8 週間 | ¥ 491,500 |
50 mg | 約6-8 週間 | ¥ 639,500 |
100 mg | 約6-8 週間 | ¥ 808,000 |
説明 | Rucaparib (AG014699) tartrate is an orally active inhibitor of PARP proteins (PARP-1, PARP-2 and PARP-3) and acts on PARP-1 (Ki: 1.4 nM).Rucaparib tartrate is a hexose hexaphosphate dehydrogenase (H6PD) inhibitor. Rucaparib tartrate has potential for use in the study of destructive resistant prostate cancer (CRPC). |
分子量 | 473.457 |
分子式 | C23H24FN3O7 |
CAS No. | 773059-22-6 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Rucaparib tartrate 773059-22-6 Inhibitor inhibitor inhibit